Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed plus Gemcitabine in Mesothelioma
NCT00061477Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in malignant pleural mesothelioma (MPM), peritoneal mesothelioma, sponsored by Eli Lilly and Company. Started Dec 2002; status: completed.
02
Drugs
pemetrexed
03
Conditions
malignant pleural mesothelioma (MPM)peritoneal mesothelioma
Beyond the preview
Go deeper on NCT00061477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061477.